Compare Organon Pharma Indonesia Tbk. (SCPI) vs Nusantara Inti Corpora Tbk (UNIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Nusantara Inti Corpora Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Nusantara Inti Corpora Tbk trades at Rp316 (market cap 23.83B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 4.4× Nusantara Inti Corpora Tbk's market cap. Which is the better fit depends on your goals.
| SCPI | UNIT | |
|---|---|---|
Market Cap | 104.4B | 23.83B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Nusantara Inti Corpora Tbk
Established in Jakarta on 1988 named PT. Aneka Keloladana. On July 2001 changed the name to PT. United Capital Indonesia. Beside as broker dealer in Capital Market, the corporate also provide the services such as financial advisory, research. Average employees are 28 staffs.On July 06 2007, PT United Capital Indonesia Tbk has changed its name as PT Nusantara Inti Corpora Tbk.
Read more on UNIT →
